Adaptive Biotechnologies Corporation (ADPT)

New Strong Sell Stocks for January 18th

Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today...

The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 11) * 10X Genomics Inc (NASDAQ: TXG) * AbbVie Inc (NYSE:...

Adaptive Biotechnologies to Collaborate with AstraZeneca in Mapping the Immune Response to Cancer Antigens to Potentially Inform the Development of Novel Diagnostics and Therapeutics

Multi-year, pan-portfolio deal extends Adaptive’s proprietary immunoSEQ T-MAP offering, originally launched for COVID-19, into oncology This transaction highlights the value of immune receptor data...

Billionaire Andreas Halvorsen’s Top 10 Stock Picks

In this article, we presented billionaire Andreas Halvorsen’s top 10 stock picks. Click to skip ahead and see Billionaire Andreas Halvorsen’s Top 5 Stock Picks. The billionaire Andreas Halvorsen�...

Adaptive Biotechnologies to Present at the 39th Annual J.P. Morgan Healthcare Conference

SEATTLE, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the ge...

Disclaimer: The data contained in Super Surge website is not necessarily real-time nor accurate and may differ from the actual market data. Prices, volumes, ratios, charts and indicators are indicative and not appropriate for trading purposes. Super Surge doesn't bear any responsibility for any trading losses you might incur as a result of using this data.